公众号 / 文章重症综合管理与镇静镇痛

赢率分析在重症监护试验中的应用

Use of the Win Ratio Analysis in Critical Care Trials.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01
一句话结论赢率法按临床重要性分层排序复合终点,可提高重症试验检出治疗效应的统计效能,但有忽略平局和终点选择排序困难等局限。

重症试验常用复合终点评估干预效应,经典分析方法对复合终点各组分赋予同等统计重要性,即使临床重要性不同(如死亡与器官衰竭)。赢率法通过将干预组每例患者与对照组对应患者按临床相关性分层比较,有效评估事件。该方法在心血管结局试验中应用渐增,在重症领域可能有用,因重症试验样本量常中等、统计效能有限且复合终点组分重要性不同。但该方法有忽略平局、终点选择与排序困难等缺点及临床解读挑战。本文以HYPO-ECMO试验为例用赢率框架重新评估。

要点

  • 经典复合终点分析对死亡和器官衰竭等组分赋予同等统计重要性,即使临床重要性不同。
  • 赢率法按临床相关性分层顺序比较干预组与对照组每例患者,评估事件效应。
  • 重症试验样本量常中等、统计效能有限,赢率法可能有助于揭示治疗效应。
  • 赢率法缺点包括忽略平局、终点选择与排序困难,以及效应量临床意义解读挑战。
  • 本文以HYPO-ECMO试验为例,用赢率框架重新评估展示该方法应用。

适用人群与场景

  • 重症监护试验人群,试验样本量常为中等,复合终点包含不同临床重要性的组分(如死亡与器官衰竭)

研究设计与关键结果

  • 本文为视角文章,介绍在重症试验中实施赢率统计的关键要素,概述该方法的优势、缺点和潜在应用。
  • 以HYPO-ECMO(静脉-动脉体外膜氧合期间低温)试验为案例,用赢率框架进行重新评估。

证据类型、等级与局限

  • 证据类型:视角文章(perspective article),含方法学概述与案例重新评估。
  • 局限:原文报告赢率法缺点包括忽略平局、终点选择与排序困难,以及效应量临床意义解读挑战。

对床旁实践的改变

  • 作者认为赢率法可能有助于揭示重症试验中的治疗效应,因这些试验样本量常中等、统计效能有限,且复合终点组分临床重要性不同。
  • 原文未据此给出具体临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Composite outcomes are commonly used in critical care trials to estimate the treatment effect of an intervention. A significant limitation of classical analytic approaches is that they assign equal statistical importance to each component in a composite, even if these do not have the same clinical importance (i.e., in a composite of death and organ failure, death is clearly more important). The win ratio (WR) method has been proposed as an alternative for trial outcomes evaluation, as it effectively assesses events based on their clinical relevance (i.e., hierarchical order) by comparing each patient in the intervention group with their counterparts in the control group. This statistical approach is increasingly used in cardiovascular outcome trials. However, WR may be useful to unveil treatment effects also in the critical care setting, because these trials are typically moderately sized, thus limiting the statistical power to detect small differences between groups, and often rely on composite outcomes that include several components of different clinical importance. Notably, the advantages of this approach may be offset by several drawbacks (such as ignoring ties and difficulties in selecting and ranking endpoints) and challenges in appropriate clinical interpretation (i.e., establishing clinical meaningfulness of the observed effect size). In this perspective article, we present some key elements to implementing WR statistics in critical care trials, providing an overview of strengths, drawbacks, and potential applications of this method. To illustrate, we conduct a reevaluation of the HYPO-ECMO (Hypothermia during Venoarterial Extracorporeal Membrane Oxygenation) trial using the WR framework as a case example.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Monzo L, Levy B, Duarte K, et al. Use of the Win Ratio Analysis in Critical Care Trials. Am J Respir Crit Care Med. 2024. PMID: 38285595. doi:10.1164/rccm.202309-1644CP

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。